Detalles de la búsqueda
1.
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.
Physiol Rev
; 102(2): 605-652, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569264
2.
Vedolizumab for the Treatment of Chronic Pouchitis.
N Engl J Med
; 388(13): 1191-1200, 2023 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988594
3.
Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
Gastroenterology
; 166(3): 396-408.e2, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949249
4.
Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study.
Gastroenterology
; 166(1): 88-102, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704112
5.
Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed Solutions.
Clin Gastroenterol Hepatol
; 22(4): 896-898.e13, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743039
6.
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
Clin Gastroenterol Hepatol
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428709
7.
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID Registry.
Clin Gastroenterol Hepatol
; 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216022
8.
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 22(1): 22-33.e6, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37716619
9.
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Clin Gastroenterol Hepatol
; 2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185396
10.
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
Clin Gastroenterol Hepatol
; 22(5): 1058-1066.e2, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38122958
11.
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.
Am J Gastroenterol
; 2024 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235763
12.
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.
Gut
; 72(10): 1838-1847, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788014
13.
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Lancet
; 399(10342): 2200-2211, 2022 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691323
14.
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Clin Gastroenterol Hepatol
; 21(4): 907-921.e2, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944832
15.
Endoscopy Unit Level Interventions to Improve Adenoma Detection Rate: A Systematic Review and Meta-Analysis.
Clin Gastroenterol Hepatol
; 21(13): 3238-3257, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080261
16.
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(4): 1050-1060.e9, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029969
17.
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.
Clin Gastroenterol Hepatol
; 21(13): 3387-3396.e1, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391059
18.
Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38122957
19.
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.
Clin Gastroenterol Hepatol
; 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951560
20.
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 21(12): 3019-3029.e5, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37061107